These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 10226604

  • 1. Luminal epithelial antigen (LEA.135) expression in adenocarcinoma of the colon.
    Miles SE, Kenwright DN, Gaskell DJ, Christie RM, Thornton A, Delahunt B.
    Anticancer Res; 1999; 19(1A):597-600. PubMed ID: 10226604
    [Abstract] [Full Text] [Related]

  • 2. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
    Jones HL, Delahunt B, Bethwaite PB, Thornton A.
    Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602
    [Abstract] [Full Text] [Related]

  • 3. LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma.
    Liu D, Baltayan A, Naritoku WY, Barr NJ, Young LL, Chaiwun B, Tsao-Wei DD, Groshen SL, Taylor CR, Torloni H, Neville AM, Cote RJ, Imam SA.
    Anticancer Res; 2000; 20(3A):1451-61. PubMed ID: 10928056
    [Abstract] [Full Text] [Related]

  • 4. Identification of a cell-surface antigen (LEA.135) associated with favorable prognosis in human breast cancer.
    Imam SA, Esteban EF, Chen RS, Cardiff RD, Taylor CR.
    Cancer Res; 1993 Jul 15; 53(14):3233-6. PubMed ID: 7686814
    [Abstract] [Full Text] [Related]

  • 5. Expression of carcinoembryonic antigen and nonspecific cross-reacting 50-kDa antigen in human normal and cancerous colon mucosa: comparative ultrastructural study with monoclonal antibodies.
    Baranov V, Yeung MM, Hammarström S.
    Cancer Res; 1994 Jun 15; 54(12):3305-14. PubMed ID: 8205554
    [Abstract] [Full Text] [Related]

  • 6. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.
    Anticancer Res; 2004 Jun 15; 24(4):2391-400. PubMed ID: 15330189
    [Abstract] [Full Text] [Related]

  • 7. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD, Snarska J, Jankowska A, Roszkowska-Jakimiec W, Puchalski Z, Zwierz K.
    Hepatogastroenterology; 2008 Jun 15; 55(82-83):388-93. PubMed ID: 18613372
    [Abstract] [Full Text] [Related]

  • 8. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma.
    Liu W, Liu Y, Zhu J, Wright E, Ding I, Rodgers GP.
    Clin Cancer Res; 2008 Feb 15; 14(4):1041-9. PubMed ID: 18281536
    [Abstract] [Full Text] [Related]

  • 9. LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ.
    Baltayan A, Naritoku WY, Chaiwun B, Tsao-Wei DD, Groshen S, Hern RA, Gusterson BA, Taylor CR, Imam SA.
    Anticancer Res; 2002 Feb 15; 22(5):2933-7. PubMed ID: 12530020
    [Abstract] [Full Text] [Related]

  • 10. Development of tumorigenicity and rearrangement of chromosome 1 correlates with down-regulation of cell-surface glycoproteins in human mammary carcinoma cell line.
    Imam SA, Pathak S, Brown N, Yilmaz A, Taylor CR.
    Anticancer Res; 1994 Feb 15; 14(1A):229-36. PubMed ID: 7513142
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM, Westra JL, de Vries EG, Boersma-van Ek W, Zwart N, Hollema H, Boezen HM, Mulder NH, Plukker JT, de Jong S, Kleibeuker JH, Koornstra JJ.
    J Clin Oncol; 2006 Nov 01; 24(31):4998-5004. PubMed ID: 17075118
    [Abstract] [Full Text] [Related]

  • 12. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
    Capuzzi D, Santoro E, Hauck WW, Kovatich AJ, Rosato FE, Baffa R, Huebner K, McCue PA.
    Cancer; 2000 Jan 01; 88(1):24-34. PubMed ID: 10618602
    [Abstract] [Full Text] [Related]

  • 13. A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer.
    Scott IS, Morris LS, Bird K, Davies RJ, Vowler SL, Rushbrook SM, Marshall AE, Laskey RA, Miller R, Arends MJ, Coleman N.
    J Pathol; 2003 Oct 01; 201(2):187-97. PubMed ID: 14517835
    [Abstract] [Full Text] [Related]

  • 14. Bcl-w expression in colorectal adenocarcinoma.
    Wilson JW, Nostro MC, Balzi M, Faraoni P, Cianchi F, Becciolini A, Potten CS.
    Br J Cancer; 2000 Jan 01; 82(1):178-85. PubMed ID: 10638987
    [Abstract] [Full Text] [Related]

  • 15. [Expression of tumor-associated antigen LEA and its significance for pathological diagnosis].
    Feng H, Song JD.
    Ai Zheng; 2002 Jun 01; 21(6):658-62. PubMed ID: 12452070
    [Abstract] [Full Text] [Related]

  • 16. Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression.
    Mhawech P, Herrmann F, Coassin M, Guillou L, Iselin CE.
    Cancer; 2003 Oct 15; 98(8):1649-57. PubMed ID: 14534881
    [Abstract] [Full Text] [Related]

  • 17. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
    Sinicrope FA, Hart J, Hsu HA, Lemoine M, Michelassi F, Stephens LC.
    Clin Cancer Res; 1999 Jul 15; 5(7):1793-804. PubMed ID: 10430084
    [Abstract] [Full Text] [Related]

  • 18. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K, Cheale M, Coleman N, Fox SB.
    Clin Cancer Res; 2002 Apr 15; 8(4):1075-81. PubMed ID: 11948116
    [Abstract] [Full Text] [Related]

  • 19. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC, Kardamakis D, Ravazoula P, Zolota V, Salakou S, Tepetes K, Kalogeropoulou C, Tsota I, Kourelis T, Makatsoris T, Karavias D, Scopa CD, Bonikos DS, Kalofonos HP, Petsas T.
    Strahlenther Onkol; 2004 Apr 15; 180(4):201-8. PubMed ID: 15057430
    [Abstract] [Full Text] [Related]

  • 20. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
    Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H.
    Gynecol Oncol; 2000 Dec 15; 79(3):424-9. PubMed ID: 11104614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.